SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018158
Filing Date
2019-05-10
Accepted
2019-05-09 18:42:04
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nite-10q_20190331.htm 10-Q 1022357
2 EX-3.1 nite-ex31_342.htm EX-3.1 756363
3 EX-31.1 nite-ex311_47.htm EX-31.1 14493
4 EX-31.2 nite-ex312_46.htm EX-31.2 14580
5 EX-32.1 nite-ex321_44.htm EX-32.1 7504
6 EX-32.2 nite-ex322_45.htm EX-32.2 7503
  Complete submission text file 0001564590-19-018158.txt   4269194

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nite-20190331.xml EX-101.INS 583918
8 XBRL TAXONOMY EXTENSION SCHEMA nite-20190331.xsd EX-101.SCH 41084
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nite-20190331_cal.xml EX-101.CAL 35089
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nite-20190331_def.xml EX-101.DEF 91405
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nite-20190331_lab.xml EX-101.LAB 254826
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nite-20190331_pre.xml EX-101.PRE 197577
Mailing Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453
Business Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453 781-778-7553
Nightstar Therapeutics plc (Filer) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38217 | Film No.: 19812274
SIC: 2836 Biological Products, (No Diagnostic Substances)